Solventum Corporation announced the pricing of a secondary offering of 8,800,000 shares of common stock.
The offering, expected to result in gross proceeds of approximately $648 million, is by the Selling Shareholder, 3M Company.
Solventum will not receive any proceeds from the offering, which is set to close around Aug. 15, 2025, subject to customary closing conditions.
Gross Proceeds Estimate
Approximately $648 million gross proceeds anticipated from the 8,800,000 shares offering.
Offering Details
All shares being sold by the Selling Shareholder; Solventum will not receive proceeds.
Underwriters
Goldman Sachs & Co. LLC and BofA Securities are serving as the underwriters for the Offering.
- Forward-looking statements in the press release outline potential risks and uncertainties, highlighting factors that could affect actual results.
- Factors include economic, regulatory, and geopolitical conditions, operational execution risks, and market competition.
The secondary offering of common stock by Solventum Corporation, with Goldman Sachs & Co. LLC and BofA Securities as underwriters, presents potential opportunities and challenges in the current market environment.